Oxymetazoline for nasal obstruction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Oct 2024: Trial started, NCT06830109
  2. 17 Feb 2025: Trial registered, NCT06830109

The trials

NCT06830109: Nasal Obstruction With Oxymetazoline and Corticosteroids

State
Under way
Phase
Phase 2
People
80 planned
Started
15 Oct 2024
Primary completion
30 Dec 2026
Arms
budesonide + oxymetazoline,
Results
None posted
  1. 15 Oct 2024: Trial started
  2. 17 Feb 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Afrin, Nasacon, Operil, Oxymetazoline Nasal Spray.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.